Showing results (121-130 of 175) with videos related to

Sort By:
Pageof 18
Oncotarget|January 2, 2018
Combined venetoclax and alvocidib in acute myeloid leukemiaJames Bogenberger, Clifford Whatcott, Nanna Hansen, et al.
The New England Journal of Medicine|January 29, 2015
Ruxolitinib versus standard therapy for the treatment of polycythemia veraAlessandro M Vannucchi, Jean Jacques Kiladjian, Martin Griesshammer, et al.
Leukemia & Lymphoma|March 19, 2024
Momelotinib vs. ruxolitinib in myelofibrosis patient subgroups by baseline hemoglobin levels in the SIMPLIFY-1 trialVikas Gupta, Stephen Oh, Timothy Devos, et al.
BMC Medical Research Methodology|August 8, 2025
Longitudinal graphics of patient-reported physical function in patients treated for hematologic malignanciesGita Thanarajasingam, Vishal Bhatnagar, Brie N Noble, et al.
European Journal of Haematology|November 27, 2015
Changes in quality of life and disease-related symptoms in patients with polycythemia vera receiving ruxolitinib or standard therapyRuben Mesa, Srdan Verstovsek, Jean-Jacques Kiladjian, et al.
The Lancet. Haematology|September 12, 2024
Efficacy and safety of fedratinib in patients with myelofibrosis previously treated with ruxolitinib (FREEDOM2): results from a multicentre, open-label, randomised, controlled, phase 3 trialClaire N Harrison, Ruben Mesa, Moshe Talpaz, et al.
Blood|April 18, 2013
Revised response criteria for polycythemia vera and essential thrombocythemia: an ELN and IWG-MRT consensus projectGiovanni Barosi, Ruben Mesa, Guido Finazzi, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 7, 2020
Real-World Outcomes of Ruxolitinib Treatment for Polycythemia VeraAlexander Coltoff, Ruben Mesa, Jason Gotlib, et al.
Leukemia|July 22, 2022
Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosisRuben Mesa, Claire Harrison, Stephen T Oh, et al.
Leukemia Research|February 22, 2018
Recent advances in the genomics and therapy of BCR/ABL1-positive and -negative chronic myeloproliferative neoplasmsTariq I Mughal, Jason Gotlib, Ruben Mesa, et al.
Pageof 18